Taiwan approves the First Autonomous Neurosurgical Navigation Robot, NaoTrac, from Brain Navi Biotechnology


Source: pharmnews.com pharmnews.com

Key Topics in this News Article:

News Snapshot:

HSINCHU, Aug. 8, 2022 /PRNewswire/ -- NaoTrac, the CE-certified neurosurgical navigation robot, achieved approval from the local government of the Ministry of Health and Welfare in Taiwan in July 2022 and is planned for submission to the FDA (U.S. Food and Drug Administration) for clearance by the end of 2022. The NaoTrac human trials were performed at the reputable Hualien Tzu-Chi Medical Center, with the External Ventricular Drain (EVD) placement abstract results published in the well-known European journal Acta Neurochirurgica. Dr. Tsung-Lang, Chiu stated, "The results of this report show that the average time spent on the patient registration was...